Niki BioSolutions (NIKI) Total Assets by Year
Niki BioSolutions, Inc. closed fiscal year 2025 with $18.7M in total assets, -$4.4M in total liabilities and $23.1M in shareholder equity. Total assets rose 15.9% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Niki BioSolutions, Inc. has filed alongside them.
Ticker history: APM became NIKI (Niki BioSolutions, Inc.) on . Earlier news and filings retain their original names and dates. View APM history.
Annual figures, oldest first. Point at a bar to read its period.
NIKI Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.7M+15.9% | $16.1M-21.9% | $20.6M-1.1% | $20.9M-4.7% | $21.9M-50.5% | $44.2M+84.6% | $24.0M-46.9% | $45.1M |
| Total Liabilities | -$4.4Mn/m | -$5.0Mn/m | -$4.2M-181.6% | $5.2Mn/m | -$1.7M-128.0% | $6.1M-33.2% | $9.1M-26.2% | $12.3M |
| Total Equity | $23.1M+9.4% | $21.1M-14.9% | $24.8M+58.1% | $15.7M-33.4% | $23.6M-43.6% | $41.8M+155.7% | $16.4M-50.6% | $33.1M |
NIKI Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q4'23Filing | Q2'23Filing | Q4'22Filing | Q2'22Filing | Q4'21Filing | Q2'21Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.7M+15.9% | $17.6M | $18.1M+2.3% | $16.1M-21.9% | N/A | $17.7M+22.8% | $20.6M-1.1% | $14.4M-40.0% | $20.9M-4.7% | $24.0M-24.3% | $21.9M-50.5% | $31.7M+36.1% |
| Total Liabilities | -$4.4Mn/m | -$5.0M | -$5.0Mn/m | -$5.0Mn/m | N/A | -$5.0Mn/m | -$4.2M-181.6% | -$7.4M-641.8% | $5.2Mn/m | $1.4M-73.8% | -$1.7M-128.0% | $5.2M-9.4% |
| Total Equity | $23.1M+9.4% | $22.5M | $23.1M+2.1% | $21.1M-14.9% | N/A | $22.7M+3.7% | $24.8M+58.1% | $21.8M-3.5% | $15.7M-33.4% | $22.6M-28.1% | $23.6M-43.6% | $31.5M+58.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Niki BioSolutions, Inc. financials
Frequently Asked Questions
Niki BioSolutions, Inc. closed fiscal year 2025 with $18.7M in total assets, -$4.4M in total liabilities and $23.1M in shareholder equity.
Niki BioSolutions, Inc. (NIKI) total assets rose by 15.9% year over year, from $16.1M to $18.7M in fiscal year 2025.
Across the 8 fiscal years this page covers, Niki BioSolutions, Inc. (NIKI) total assets went from $45.1M in fiscal year 2018 to $18.7M in fiscal year 2025.
Niki BioSolutions, Inc. (NIKI) reported $18.7M in total assets in Q4 2025. This represents an increase of 15.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Niki BioSolutions, Inc. (NIKI) reported on that line in every period on record.